Marshall Wace
NERV icon

Marshall Wace’s Minerva Neurosciences NERV Stock Holding History

Marshall Wace’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
+218,759
New +$1.25M ﹤0.01% 1999
2017
Q1 		– Sell
-55,353
Closed -$5.2M – 597
2016
Q4 		$5.2M Buy
55,353
+1,511
+3% +$154K 0.03% 460
2016
Q3 		$6.08M Buy
53,842
+21,154
+65% +$2.05M 0.04% 372
2016
Q2 		$2.67M Buy
+32,688
New +$2.08M 0.02% 522

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Marshall Wace's NERV Position: Q1 2026 in Review

Marshall Wace opened a new position in Minerva Neurosciences (NERV) in Q1 2026: 218,759 shares worth $1.32M. The stake represents ﹤0.01% of the portfolio and ranks #1999 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NERV as recently as Q4 2016.

Marshall Wace first reported a position in NERV in Q2 2016 and has held it in 4 quarters since. The position peaked at $6.08M in Q3 2016. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Marshall Wace held 218,759 shares of Minerva Neurosciences worth $1.32M as of Q1 2026.
  • Minerva Neurosciences was a new Marshall Wace position in Q1 2026.
  • Minerva Neurosciences made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1999 holding.
  • Marshall Wace first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 4 quarters since.
  • Marshall Wace's Minerva Neurosciences position peaked at $6.08M in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.